In addition, there is growing evidence that the phosphatidylinositol 3-kinase (PI3K)/AKT pathway is associated with the pathophysiology of depression and the antidepressant-like effect of different compounds (88–90). This evidence concerns the gene AKT1 and depressive symptom measurement.